Last Price$180.63.6%
Market Cap$1,194.8M
LTM Research & Development Expenses (R&D)
$0.0
YoY Growth
N/A
3Y CAGR
N/A
5Y CAGR
N/A
Stock quality & Intrinsic value
6/10
25.8% overvalued
CRA International, Inc. Research & Development Expenses (R&D)
Annual
Quarterly
LTM
Crunching data... Almost there!
| Nov'05 | Nov'06 | Nov'07 | Nov'08 | Nov'09 | Nov'10 | Dec'11 | Dec'12 | Dec'13 | Jan'15 | Jan'16 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Jan'21 | Jan'22 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research & Development Expenses (R&D) | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
Overvalued or undervalued?
Check the intrinsic value for CRAI
and see if it's the right time to invest.
CRA International, Inc. (CRAI) Research & Development Expenses (R&D) comparison analysis
General
LTM Research & Development Expenses (R&D)
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
CRA International, Inc.CRAI
$0.0
N/A
N/A
N/A
Median Peer Set
$0.0
0.0%
0.0%
0.0%
Equifax Inc.EFX
$0.0
N/A
N/A
N/A
Exponent, Inc.EXPO
$0.0
N/A
N/A
N/A
Franklin Covey Co.FC
$0.0
N/A
N/A
N/A
FTI Consulting, Inc.FCN
$0.0
N/A
N/A
N/A
Huron Consulting Group Inc.HURN
$0.0
(100.0%)
(100.0%)
(100.0%)
ICF International, Inc.ICFI
$0.0
N/A
N/A
N/A
Booz Allen Hamilton Holding CorporationBAH
$0.0
N/A
N/A
N/A
Resources Connection, Inc.RGP
$0.0
N/A
N/A
N/A
TransUnionTRU
$0.0
N/A
N/A
N/A
Verisk Analytics, Inc.VRSK
$0.0
(100.0%)
N/A
(100.0%)
CRAI key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Nov'05 | Nov'06 | Nov'07 | Nov'08 | Nov'09 | Nov'10 | Dec'11 | Dec'12 | Dec'13 | Jan'15 | Jan'16 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Jan'21 | Jan'22 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 295.5 36.3% | 349.9 18.4% | 394.6 12.8% | 376.8 (4.5%) | 301.6 (19.9%) | 309.7 2.7% | 305.2 (1.4%) | 270.4 (11.4%) | 278.4 3.0% | 306.4 10.0% | 303.6 (0.9%) | 324.8 7.0% | 370.1 13.9% | 417.6 12.9% | 451.4 8.1% | 508.4 12.6% | 565.9 11.3% | 590.9 4.4% | 624.0 5.6% | 687.4 10.2% |
| Cost of Goods Sold (COGS) | 174.7 | 221.3 | 246.0 | 250.1 | 199.9 | 213.5 | 199.4 | 182.4 | 189.3 | 206.8 | 207.7 | 227.4 | 258.8 | 289.2 | 317.8 | 370.7 | 400.1 | 410.1 | 452.2 | 479.9 |
% margin | 120.8 40.9% | 128.6 36.7% | 148.6 37.7% | 126.6 33.6% | 101.8 33.7% | 96.1 31.0% | 105.8 34.7% | 88.0 32.5% | 89.2 32.0% | 99.6 32.5% | 95.9 31.6% | 97.4 30.0% | 111.2 30.1% | 128.5 30.8% | 133.6 29.6% | 137.7 27.1% | 165.9 29.3% | 180.8 30.6% | 171.7 27.5% | 207.5 30.2% |
| Operating Expenses | 76.6 | 80.6 | 99.9 | 105.5 | 84.6 | 86.5 | 76.8 | 74.4 | 70.7 | 75.5 | 79.0 | 78.5 | 95.5 | 99.5 | 104.3 | 102.9 | 110.1 | 122.1 | 115.1 | 136.7 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, General & Administrative Expenses (SG&A) | 76.6 | 80.6 | 99.9 | 105.5 | 76.1 | 80.0 | 71.8 | 67.2 | 64.2 | 69.1 | 72.4 | 70.6 | 86.5 | 89.5 | 93.6 | 90.0 | 97.4 | 110.1 | 115.1 | 125.1 |
% margin | 44.2 15.0% | 48.0 13.7% | 48.8 12.4% | 21.1 5.6% | 17.1 5.7% | 9.6 3.1% | 29.1 9.5% | (57.8) (21.4%) | 18.5 6.7% | 24.0 7.8% | 12.4 4.1% | 18.9 5.8% | 15.8 4.3% | 28.9 6.9% | 29.3 6.5% | 34.8 6.8% | 55.7 9.8% | 58.7 9.9% | 56.6 9.1% | 70.8 10.3% |
| Interest Income | 2.1 | 5.1 | 5.5 | 3.1 | 0.5 | 0.4 | 0.3 | 0.3 | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 1.3 | 1.2 | 1.0 | 1.8 | 0.0 | 0.0 |
| Interest Expense | 3.4 | 3.4 | 3.3 | 3.5 | 2.9 | 3.5 | 0.9 | 0.3 | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | 0.6 | 1.3 | 1.2 | 1.0 | 1.8 | 3.8 | 4.4 |
| Pre-tax Income | 43.2 | 49.4 | 50.5 | 23.3 | 15.3 | 5.3 | 28.1 | (58.0) | 17.9 | 23.3 | 11.8 | 21.9 | 15.2 | 28.9 | 26.8 | 33.6 | 54.3 | 58.8 | 52.3 | 66.2 |
% effective tax rate | 18.5 42.9% | 21.2 42.9% | 19.7 39.0% | 14.2 61.2% | 8.1 52.9% | 4.0 75.4% | 11.1 39.7% | (5.2) 8.9% | 6.7 37.3% | 9.9 42.5% | 5.5 46.5% | 7.7 35.0% | 7.5 49.2% | 6.5 22.3% | 6.1 22.6% | 9.1 27.1% | 12.6 23.2% | 15.2 25.8% | 13.8 26.4% | 19.6 29.6% |
% margin | 24.6 8.3% | 27.4 7.8% | 32.6 8.3% | 8.7 2.3% | 7.8 2.6% | 2.0 0.6% | 16.9 5.5% | (53.0) (19.6%) | 11.4 4.1% | 13.6 4.5% | 7.7 2.5% | 12.9 4.0% | 7.6 2.1% | 22.5 5.4% | 20.7 4.6% | 24.5 4.8% | 41.7 7.4% | 43.6 7.4% | 38.5 6.2% | 46.7 6.8% |
| EPS | 2.34 | 2.40 | 2.91 | 0.76 | 0.74 | 0.18 | 1.60 | (5.21) | 1.13 | 1.40 | 0.84 | 1.50 | 0.91 | 2.62 | 2.63 | 3.14 | 5.59 | 6.02 | 5.47 | 6.84 |
| Diluted EPS | 2.13 | 2.24 | 2.68 | 0.74 | 0.73 | 0.18 | 1.57 | (5.21) | 1.12 | 1.38 | 0.83 | 1.49 | 0.89 | 2.62 | 2.53 | 3.07 | 5.45 | 5.91 | 5.39 | 6.75 |
% margin | 52.3 17.7% | 58.2 16.6% | 58.9 14.9% | 38.3 10.2% | 26.0 8.6% | 15.3 4.9% | 34.1 11.2% | (51.9) (19.2%) | 24.9 8.9% | 30.4 9.9% | 19.0 6.2% | 30.3 9.3% | 24.6 6.6% | 39.6 9.5% | 49.4 10.9% | 59.7 11.7% | 81.0 14.3% | 86.4 14.6% | 81.9 13.1% | 97.5 14.2% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is CRA International, Inc.'s Research & Development Expenses (R&D)?
As of today, CRA International, Inc.'s last 12-month Research & Development Expenses (R&D) is $0.0, based on the financial report for Dec 28, 2024 (Q4’2024).
2) What is CRA International, Inc.'s Research & Development Expenses (R&D) growth rate?
Over the last year, CRA International, Inc.'s Research & Development Expenses (R&D) growth was N/A. The average annual Research & Development Expenses (R&D) growth rates for CRA International, Inc. have been N/A over the past three years, N/A over the past five years.